Literature DB >> 8647839

The association of cardiac dystrophin with myofibrils/Z-disc regions in cardiac muscle suggests a novel role in the contractile apparatus.

H Meng1, J J Leddy, J Frank, P Holland, B S Tuana.   

Abstract

Dystrophin serves a variety of roles at the cell membrane through its associations, and defects in the dystrophin gene can give rise to muscular dystrophy and genetic cardiomyopathy. We investigated localization of cardiac dystrophin to determine potential intracellular sites of association. Subcellular fractionation revealed that while the majority of dystrophin was associated with the sarcolemma, about 35% of the 427-kDa form of dystrophin was present in the myofibrils. The dystrophin homolog utrophin was detectable only in the sarcolemmal membrane and was absent from the myofibrils as were other sarcolemmal glycoproteins such as adhalin and the sodium-calcium exchanger. Extraction of myofibrils with KC1 and detergents could not solubilize dystrophin. Dystrophin could only be dissociated from the myofibrillar protein complex in 5 M urea followed by sucrose density gradient centrifugation where it co-fractionated with one of two distinctly sedimenting peaks of actin. Immunoelectron microscopy of intracellular regions of cardiac muscle revealed a selective labeling of Z-discs by hystrophin antibodies. In the genetically determined cardiomyopathic hamster, strain CHF 147, the time course of development of cardiac insufficiency correlated with an overall 75% loss of myofibrillar dystrophin. These findings collectively show that a significant pool of the 427-kDa form of cardiac dystrophin was specifically associated with the contractile apparatus at the Z-discs, and its loss correlated with progression to cardiac insufficiency in genetic cardiomyopathy. The loss of distinct cellular pools of dystrophin may contribute to the tissue-specific pathophysiology in muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647839     DOI: 10.1074/jbc.271.21.12364

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Cardiac syntrophin isoforms: species-dependent expression, association with dystrophin complex and subcellular localization.

Authors:  Yuko Iwata; Munekazu Shigekawa; Shigeo Wakabayashi
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  Intracellular energetic units in healthy and diseased hearts.

Authors:  Enn K Seppet; Margus Eimre; Tiia Anmann; Evelin Seppet; Nadezhda Peet; Tuuli Käämbre; Kalju Paju; Andres Piirsoo; Andrei V Kuznetsov; Marko Vendelin; Frank N Gellerich; Stephan Zierz; Valdur A Saks
Journal:  Exp Clin Cardiol       Date:  2005

3.  Cardiac-Specific Expression of ΔH2-R15 Mini-Dystrophin Normalized All Electrocardiogram Abnormalities and the End-Diastolic Volume in a 23-Month-Old Mouse Model of Duchenne Dilated Cardiomyopathy.

Authors:  Nalinda B Wasala; Jin-Hong Shin; Yi Lai; Yongping Yue; Federica Montanaro; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2018-03-22       Impact factor: 5.695

4.  Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.

Authors:  J Manuel Pioner; Xuan Guan; Jordan M Klaiman; Alice W Racca; Lil Pabon; Veronica Muskheli; Jesse Macadangdang; Cecilia Ferrantini; Michael R Hoopmann; Robert L Moritz; Deok-Ho Kim; Chiara Tesi; Corrado Poggesi; Charles E Murry; Martin K Childers; David L Mack; Michael Regnier
Journal:  Cardiovasc Res       Date:  2020-02-01       Impact factor: 10.787

5.  Utrophin and dystrophin-associated glycoproteins in normal and dystrophin deficient cardiac muscle.

Authors:  F Rivier; A Robert; M Royuela; G Hugon; A Bonet-Kerrache; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  1999-04       Impact factor: 2.698

Review 6.  The extracellular matrix and the cytoskeleton in heart hypertrophy and failure.

Authors:  S Jane-Lise; S Corda; C Chassagne; L Rappaport
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

7.  Dystrophin and the cardiomyocyte membrane cytoskeleton in the healthy and failing heart.

Authors:  R R Kaprielian; N J Severs
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

8.  Sarcolemmal fragility secondary to the degradation of dystrophin in dilated cardiomyopathy, as estimated by electron microscopy.

Authors:  Tomie Kawada; Chieko Hemmi; Satoru Fukuda; Asaki Tezuka; Kuniaki Iwasawa; Mikio Nakazawa; Hiroshi Sato; Teruhiko Toyo-Oka
Journal:  Exp Clin Cardiol       Date:  2003

9.  Arginyltransferase regulates alpha cardiac actin function, myofibril formation and contractility during heart development.

Authors:  Reena Rai; Catherine C L Wong; Tao Xu; N Adrian Leu; Dawei W Dong; Caiying Guo; K John McLaughlin; John R Yates; Anna Kashina
Journal:  Development       Date:  2008-10-23       Impact factor: 6.868

Review 10.  Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy.

Authors:  Josè Manuel Pioner; Alessandra Fornaro; Raffaele Coppini; Nicole Ceschia; Leonardo Sacconi; Maria Alice Donati; Silvia Favilli; Corrado Poggesi; Iacopo Olivotto; Cecilia Ferrantini
Journal:  Front Physiol       Date:  2020-05-12       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.